- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Inhibition of YB-1 alone or in combination with TMZ...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment Gao, Yuanyuan
Abstract
Glioblastoma is a rare, but devastating brain tumor. Recent studies showed that GBM is correlated with Y-box binding protein-1 (YB-1) overexpression both in pediatric and adult patients. YB-1 is a member of the cold shock domain protein superfamily. It performs a wide variety of cellular functions, including regulation of cell growth, apoptosis, transcription, translation and drug resistance. Our goal was to determine the potential therapeutic value of targeting YB-1 in GBM. We carried out both transient and stable YB-1 knock-down, using siRNA and shRNA in GBM cell lines. The loss of YB-1 inhibited the cologenicity of SF188 in soft agar, and suppressed cell invasiveness in matrigel invasion assay. Furthermore, YB-1 stable knock-down delayed the onset of tumor formation in mice and suppressed tumor growth by 30%. Beyond its role in tumor growth and invasion, YB-1 is also strongly linked to drug resistance. We therefore addressed whether it plays roles in taxol (TXL) and temozolomide (TMZ) sensitivity. TXL is a commonly used anti-tumor drug and TMZ is the leading compound in GBM treatment. We evaluated YB-1 stable knock-down GBM cells sensitivity to these drugs both in monolayer and soft agar. Interestingly, we see a significant increase of apoptosis induced by TXL and TMZ in YB-1 silenced cells. Also, an enhanced suppression of cologenicity by TXL in soft agar was examined in YB-1 silenced cells. These results suggest that YB-1 modulates cell invasive ability, cologenicity, tumorgenicity in vivo and response to chemotherapy. With improved understanding of YB-1 roles in GBM, novel therapeutic approaches developed to target it are expected to provide a promising therapeutic benefit in treatment of GBM.
Item Metadata
Title |
Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2009
|
Description |
Glioblastoma is a rare, but devastating brain tumor. Recent studies showed that GBM is correlated with Y-box binding protein-1 (YB-1) overexpression both in pediatric and adult patients. YB-1 is a member of the cold shock domain protein superfamily. It performs a wide variety of cellular functions, including regulation of cell growth, apoptosis, transcription, translation and drug resistance. Our goal was to determine the potential therapeutic value of targeting YB-1 in GBM. We carried out both transient and stable YB-1 knock-down, using siRNA and shRNA in GBM cell lines. The loss of YB-1 inhibited the cologenicity of SF188 in soft agar, and suppressed cell invasiveness in matrigel invasion assay. Furthermore, YB-1 stable knock-down delayed the onset of tumor formation in mice and suppressed tumor growth by 30%. Beyond its role in tumor growth and invasion, YB-1 is also strongly linked to drug resistance. We therefore addressed whether it plays roles in taxol (TXL) and temozolomide (TMZ) sensitivity. TXL is a commonly used anti-tumor drug and TMZ is the leading compound in GBM treatment. We evaluated YB-1 stable knock-down GBM cells sensitivity to these drugs both in monolayer and soft agar. Interestingly, we see a significant increase of apoptosis induced by TXL and TMZ in YB-1 silenced cells. Also, an enhanced suppression of cologenicity by TXL in soft agar was examined in YB-1 silenced cells.
These results suggest that YB-1 modulates cell invasive ability, cologenicity, tumorgenicity in vivo and response to chemotherapy. With improved understanding of YB-1 roles in GBM, novel therapeutic
approaches developed to target it are expected to provide a promising therapeutic benefit in treatment of GBM.
|
Extent |
1960202 bytes
|
Genre | |
Type | |
File Format |
application/pdf
|
Language |
eng
|
Date Available |
2009-11-09
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution-NonCommercial-NoDerivatives 4.0 International
|
DOI |
10.14288/1.0068058
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2009-05
|
Campus | |
Scholarly Level |
Graduate
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International